Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

Bayer is pressing ... given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was no significant observed increase in bleeding with asundexian at any dose or compared ...

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

Is daily aspirin really necessary for heart disease prevention? Find out the truth behind the changing recommendations.

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new stu ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

Description The goal of the trial was to evaluate treatment with famotidine compared with placebo among patients taking low-dose aspirin. Hypothesis Famotidine would be more effective in ...

India's Bayer CropScience Q2 profit falls on pricing pressure November 13, 2024 Europe's main index plunged 2% to a near three-month low on Tuesday ... of the higher dose version of its ...

Bayer shares are trading at a multi-decade low, but shares may still be overvalued. If we add Bayer's net debt of $38.8 billion to Bayer's market cap of $19.7 billion, we can calculate the company ...